Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 18,000 shares at $0.28 ($5K) on 2019-08-30, disclosed to the SEC on 2019-09-03.
Open-market purchase of $5k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 2,500 | $650 | 13.0% |
| 2 | $0.28 | 5,000 | $1K | 28.1% |
| 3 | $0.28 | 10,500 | $3K | 58.9% |
| Total | $0.28 avg | 18,000 | $5K | 100% |
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |